Randall Hyer from Dynavax: Developing a Vaccine to Prevent Hepatitis B in Diabetes Patients

Video

Research in the medical field covers a wide range of conditions and ways to not only treat them but also prevent them. Research is being done on a new vaccine for hepatitis B which has shown to be effective in patients with diabetes.

Research in the medical field covers a wide range of conditions and ways to not only treat them but also prevent them. Research is being done on a new vaccine for hepatitis B which has shown to be effective in patients with diabetes.

Randall N. Hyer, MD, PhD, MPH, from Dynavax discussed a vaccine his company is developing that would prevent the spread of hepatitis B from this patient population and others. Hyer said patients with diabetes are succeptible to this form of hepatitis for a number of circumstances but with the right care it can be largely preventable. Hyer discussed the vaccine during the American Diabetes Association's annual meeting in New Orleans.

Related Videos
Noa Krugliak Cleveland, MD | Credit: University of Chicago
Caroline Sisson, MMS, PA-C: Updates in Pulmonary Function Testing
Ali Rezaie, MD | Credit: X
Should We Reclassify Diabetes Subtypes?
Remo Panaccione, MD | Credit: University of Calgary
Francisca Joly, MD, PhD | Credit: The Transplantation Society
Primary Care Roles in Alzheimer Diagnosis, with Theresa Sivers-Teixeira, MSPA, PA-C
Heart Failure Treatment Outcomes and Contraindications
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
© 2024 MJH Life Sciences

All rights reserved.